B-Type Natriuretic Peptide Can Distinguish Ischemic Stroke Subtypes Better than Other Cardiac Biomarkers

BACKGROUND: The primary benefit to patients of being able to distinguish among subtypes of ischemic stroke (IS) is creation of a better treatment decision-making process. Current classification methods are complex and time-consuming, requiring hours to days. Blood-based cardiac biomarker measurement...

Descripción completa

Detalles Bibliográficos
Autores principales: Liang, Ping, Han, Shuang, Jiang, Yucen, Miao, Huikai, Qi, Xiaowei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: International Scientific Literature, Inc. 2023
Materias:
Clinical Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10288888/
https://www.ncbi.nlm.nih.gov/pubmed/37335813
http://dx.doi.org/10.12659/MSM.939829

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10288888/
https://www.ncbi.nlm.nih.gov/pubmed/37335813
http://dx.doi.org/10.12659/MSM.939829

Ejemplares similares